Business Context and Reporting Period
This Form 8-K Current Report was filed by Brucker Corporation on August 6, 2015. The filing reports a corporate governance event regarding the expansion of the Board of Directors.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to the announcement of a new director appointment.
Material Changes
- Board Expansion: The Board of Directors approved an increase in the number of directors from eleven to twelve.
- New Appointment: Dr. Hermann Requardt was elected to fill the newly created vacancy in Class II, effective immediately.
- Term: Dr. Requardt's term will expire at the Company's 2017 Annual Meeting of Stockholders.
Management Commentary and Background
Dr. Hermann Requardt brings significant experience in the life science and healthcare technology sectors. His background includes:
- Former Chief Executive Officer of the healthcare division of Siemens AG (2009–February 2015).
- Former Chief Technology Officer of Siemens AG (2008–2011).
- Member of the Siemens AG Managing Board (2006–January 2015).
- Current roles include independent strategic advisor to European life science companies, Vice Chairman of Fraunhofer-Gesellschaft, and member of the Executive Board of Acatech.
- He holds a Ph.D. in Biophysics from the University of Frankfurt.
Dr. Requardt's compensation will be consistent with that of other non-employee directors as described in the Company's 2015 proxy statement. No other arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K exist.
Investor Verification Checklist
- Verify the total number of directors on the Board is now twelve.
- Confirm Dr. Hermann Requardt's term expiration date is set for the 2017 Annual Meeting.
- Review the Company's definitive proxy statement filed on April 14, 2015, for details on non-employee director compensation.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.